Related Experiment Video
Updated: Mar 3, 2026

Non-invasive In Vivo Fluorescence Optical Imaging of Inflammatory MMP Activity Using an Activatable Fluorescent Imaging Agent
Published on: May 8, 2017
Higher levels of matrix metalloproteinase-3 in patients with RA reflect disease activity and structural damage
Martina Skacelova1, Zuzana Hermanova2, Pavel Horak1
1Department of Internal Medicine III - Nephrology, Rheumatology and Endocrinology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic.
Aims:
To evaluate the serum levels of matrix metalloproteinase-3 (MMP-3) as a potential marker of disease activity and joint damage in 92 patients with rheumatoid arthritis (RA), compared to 24 osteoarthritis (OA) patients and 26 healthy controls.
Methods:
The concentrations of MMP-3 were measured by ELISA using the commercial kit AESKULISA DF MMP-3 (AESKU.Diagnostics, Germany) and compared with other laboratory parameters routinely used to assess the disease status, clinical score (DAS28) and radiographic stage in the group of RA patients.
Results:
The mean serum concentrations of MMP-3 were 199.1 ± 160 ng/mL in RA patients, 113.9 ± 96.9 ng/mL in OA patients and 48.3 ± 19.2 in healthy controls. The differences were highly significant: RA patients and healthy controls (P<0.0001), RA and OA patients (P=0.008) as well as between OA patients and controls (P=0.009). MMP-3 concentrations were further compared with other laboratory parameters and clinical and structural damage data. There were correlations between MMP-3 and CRP (r=0.304, P<0.01), DAS28 (r=0.301, P<0.05), levels of anti-cyclic citrullinated peptide antibodies (r=0.241, P<0.05), erythrocyte sedimentation rate (r=0.200, P=0.059) and radiographic disease stage (r=0.197, P=0.063).
Conclusion:
These results demonstrated that measurement of MMP-3 could become a marker of disease activity in RA patients.
Insights
Matrix metalloproteinase-3 (MMP-3) serum levels are significantly elevated in rheumatoid arthritis (RA) patients, indicating its potential as a marker for disease activity and joint damage.
Area of Science:
- Rheumatology
- Biochemistry
- Immunology
Background:
- Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by joint inflammation and damage.
- Identifying reliable biomarkers for disease activity and progression is crucial for effective RA management.
- Matrix metalloproteinase-3 (MMP-3) is an enzyme involved in extracellular matrix degradation, implicated in joint pathology.
Purpose of the Study:
- To investigate serum MMP-3 levels as a potential biomarker for disease activity and joint damage in RA.
- To compare MMP-3 concentrations in RA patients with those in osteoarthritis (OA) patients and healthy controls.
- To correlate MMP-3 levels with established clinical and laboratory markers of RA disease status.
Main Methods:
- Serum samples were collected from 92 RA patients, 24 OA patients, and 26 healthy controls.
- MMP-3 concentrations were quantified using ELISA (AESKU.Diagnostics).
- MMP-3 levels were compared with clinical scores (DAS28), radiographic staging, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and anti-cyclic citrullinated peptide (anti-CCP) antibodies.
Main Results:
- Mean serum MMP-3 levels were significantly higher in RA patients (199.1 ng/mL) compared to OA patients (113.9 ng/mL) and healthy controls (48.3 ng/mL) (P<0.0001).
- Significant correlations were observed between MMP-3 levels and CRP (r=0.304), DAS28 (r=0.301), anti-CCP antibodies (r=0.241), ESR (r=0.200), and radiographic disease stage (r=0.197).
- These findings highlight MMP-3's association with various indicators of RA disease activity and structural damage.
Conclusions:
- Serum MMP-3 measurement shows promise as a valuable biomarker for assessing disease activity in rheumatoid arthritis.
- Elevated MMP-3 levels reflect active joint inflammation and potential for joint damage in RA patients.
- MMP-3 could serve as an adjunct marker to complement existing methods for RA monitoring.
Related Concept Videos
Role of Matrix Metalloproteases in Degradation of ECM
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Extracellular Matrix
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
The Extracellular Matrix
In order to maintain tissue organization, many animal cells are surrounded by structural molecules that make up the extracellular matrix (ECM). Together, the molecules in the ECM maintain the structural integrity of tissue as well as the remarkable specific properties of certain tissues.
Composition of the Extracellular Matrix
The extracellular matrix (ECM) is commonly composed of ground substance, a gel-like fluid, fibrous components, and many structurally and functionally diverse...

